Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads
Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear...
Trending Now
Trump Touts War Deaths Chart to Pat Himself on the Back Over Iran Casualties Compared to Vietnam and Korea (189)
Trump claims US will strike Iran’s Pickaxe Mountain ‘probably pretty soon’ (155)
Business News | White House Science Report Urges Regulatory Reforms, AI-led Research, Funding Overhaul to Boost US Innovation (97)
Bus fares to be capped at £2... thanks to £500MILLION 'cost-of-living' splurge (91)
Sgt. Angel S. Rampersad announced as third soldier ‘believed to be deceased’ following Iranian attack on Jordan Air Base (68)
Fox Business Journo Slams Trump’s New Canada Tariffs: ‘Not a Time to Be Screwing Around’ (61)
Woman's remains identified by DNA in Virginia, exposing second alleged murder linked to same 4 suspects (43)
Likely Maine Democratic Senate nominee says he won't back Schumer for leader (41)
Trump Touts War Deaths Chart to Pat Himself on the Back Over Iran Casualties Compared to Vietnam and Korea (189)
Trump claims US will strike Iran’s Pickaxe Mountain ‘probably pretty soon’ (155)
Business News | White House Science Report Urges Regulatory Reforms, AI-led Research, Funding Overhaul to Boost US Innovation (97)
Bus fares to be capped at £2... thanks to £500MILLION 'cost-of-living' splurge (91)
Sgt. Angel S. Rampersad announced as third soldier ‘believed to be deceased’ following Iranian attack on Jordan Air Base (68)
Fox Business Journo Slams Trump’s New Canada Tariffs: ‘Not a Time to Be Screwing Around’ (61)
Woman's remains identified by DNA in Virginia, exposing second alleged murder linked to same 4 suspects (43)
Likely Maine Democratic Senate nominee says he won't back Schumer for leader (41)
Full News Feed
Safe from AI: which jobs will help you thrive in the future?
Experts say there will still be opportunities ahead in everything from teaching to hotels and the...
Related Coverage
‘A new consumer’: how weight-loss drugs are shaking up clothes shopping
As they slim down, UK and US users of GLP-1 jabs and pills are changing their spending habits...
Burnham urged to ditch ‘dangerous’ UK-US NHS drug deal
Exclusive: health groups call on expected next prime minister to rip up agreement, which analysis...
Related Coverage
How US-UK drug deal will benefit patients | Letters
Many new medicines have reached NHS patients as a result of the government’s reformed pricing...
Wegovy weight-loss pill goes on sale at UK high street and online pharmacies
Thousands of people begin receiving their first deliveries of the medication made by Novo Nordisk...
Starmer’s goodbye gift to Britain: a US pharma deal that could be more lethal than Covid | Aditya Chakrabortty
This shadowy treaty on medicine imports will cost the NHS billions and take funding away from...
Related Coverage
‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year
Exclusive: Fears that US companies may withdraw more medicines as global markets react to policy...
Referral Link
Why a surge in sexually transmitted infections in Europe should worry everybody | Peter Beyer
Drug-resistant bacteria are no longer confined to hospital settings but are spreading into...
NHS patients face worst drug shortages on record, say pharmacists and GPs
Supply problems pose risk to health, with common painkillers, epilepsy medication and HRT...
The peptide boom: how the US got hooked on unregulated ‘miracle’ drugs | On the Ground
Across the US, thousands of people are injecting themselves with unregulated peptides in pursuit of...
London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
Poolbeg Pharma to test the treatment in NHS hospitals and says it is also developing a GLP-1 weight...
Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?
The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving...
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
British drugmaker’s new chief executive Luke Miels announces one of its biggest dealsBusiness...